» Articles » PMID: 1106353

Discontinuance of Immunosuprression in Renal Transplant Patients

Overview
Journal Arch Surg
Specialty General Surgery
Date 1975 Dec 1
PMID 1106353
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Immunosuppressive therapy was discontinued in six patients for an average of 27 months. In these six patients, only two rejections have occurred. A survey of other transplant centers showed that in such patients rejection was often delayed weeks or months after therapy was stopped. Once immunosuppressive therapy has been stopped, for whatever reason, and rejection has not occurred, consideration should be given to not resuming therapy unless signs of rejection appear.

Citing Articles

Regulatory B Cells in Solid Organ Transplantation: From Immune Monitoring to Immunotherapy.

Elias C, Chen C, Cherukuri A Transplantation. 2023; 108(5):1080-1089.

PMID: 37779239 PMC: 10985051. DOI: 10.1097/TP.0000000000004798.


Regulatory B cells: TIM-1, transplant tolerance, and rejection.

Cherukuri A, Mohib K, Rothstein D Immunol Rev. 2021; 299(1):31-44.

PMID: 33484008 PMC: 7968891. DOI: 10.1111/imr.12933.


Validation Study of an Operational Tolerance Signature in Korean Kidney Transplant Recipients.

Lee Y, Seo J, Kim Y, Moon J, Kim J, Jeong K Immune Netw. 2018; 18(5):e36.

PMID: 30402331 PMC: 6215901. DOI: 10.4110/in.2018.18.e36.


Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients.

Newell K, Adams A, Turka L Hum Immunol. 2018; 79(5):380-387.

PMID: 29448053 PMC: 5924709. DOI: 10.1016/j.humimm.2018.02.007.


Operational tolerance in kidney transplantation and associated biomarkers.

Massart A, Ghisdal L, Abramowicz M, Abramowicz D Clin Exp Immunol. 2017; 189(2):138-157.

PMID: 28449211 PMC: 5508347. DOI: 10.1111/cei.12981.